Second Line Capital, LLC
- SEC CIK
- 0001992879
- Latest filing
- Sep 2, 2026
NTLA holding history
Intellia Therapeutics, Inc. in every 13F filed by Second Line Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −63,027−100.0% | Sold out | Holders |
| Q3 2025 | 63,027 | $1.09M | 0.2% | 00.0% | Unchanged | Holders |
| Q2 2025 | 63,027 | $591.2K | 0.1% | −16,672−20.9% | Reduced | Holders |
| Q1 2025 | 79,699 | $566.7K | 0.1% | −51,423−39.2% | Reduced | Holders |
| Q4 2024 | 131,122 | $1.53M | 0.4% | +131,122 | New | Holders |